Red Blood Cell Clinical Trials

7 recruitingLast updated: May 13, 2026

There are 7 actively recruiting red blood cell clinical trials across 9 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 4. Top locations include Hamilton, Ontario, Canada, Antony, France, Bobigny, France. Updated daily from ClinicalTrials.gov.


Red Blood Cell Trials at a Glance

7 actively recruiting trials for red blood cell are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Hamilton, Antony, and Bobigny. Lead sponsors running red blood cell studies include Imagine Institute, Jose Cancelas, and Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Browse red blood cell trials by phase

Treatments under study

About Red Blood Cell Clinical Trials

Looking for clinical trials for Red Blood Cell? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Red Blood Cell trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Red Blood Cell clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 2

Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor

Sickle Cell DiseaseStem Cell Transplant ComplicationsPure Red Cell Aplasia+1 more
University of Calgary12 enrolled1 locationNCT03214354
Recruiting
Phase 1

Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery and Survival After Autologous Transfusion

Healthy Volunteer Red Blood Cell Labeling Study; Not Disease Focused
Jose Cancelas20 enrolled2 locationsNCT07446647
Recruiting
Phase 4

Effects of Donor-recipient Sex-matched Blood Transfusion on Patient Outcomes

CardiovascularRed Blood Cell TransfusionsSex Differences+3 more
Michelle Zeller11,082 enrolled8 locationsNCT06840756
Recruiting

Pathophysiological Explorations of Red Blood Cells

Red Blood Cell Disorder
Imagine Institute3,750 enrolled25 locationsNCT03541525
Recruiting
Not Applicable

Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO

TransfusionAnemiaECMO+2 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)526 enrolled12 locationsNCT06560164
Recruiting
Not Applicable

The Effect of Retrograde Autologous Priming on Transfusion Requirements After Cardiac Surgery

Red blood cell transfusion
Population Health Research Institute4,500 enrolled4 locationsNCT06230198
Recruiting

Red Cell Life Span (RBC) in Chronic Kidney Disease (CKD)

Red blood cell life spanChronic Kidney Disease
University of Otago56 enrolled1 locationACTRN12610000145000